AbbVie Inc. — Director's Dealing 2023

Mar 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-02-28

Reporting Person: Sorg Elaine K. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-28	Common Stock, $0.01 par value	F	19850	$154.28	Disposed	42829	Direct
2023-03-01	Common Stock, $0.01 par value	M	15003	$93.50	Acquired	57832	Direct
2023-03-01	Common Stock, $0.01 par value	S	15003	$155	Disposed	42829	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Option (Right to Buy)	$93.50	M	15003	Disposed	2030-02-19	Common Stock (15003)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.